Dr. Thomas Klein, MD
Claim this profileGSK Investigational Site
Studies Non-alcoholic Fatty Liver Disease
Studies Fatty Liver Disease
5 reported clinical trials
9 drugs studied
Affiliated Hospitals
Clinical Trials Thomas Klein, MD is currently running
GSK4527226
for Early Alzheimer's Disease
The aim of this study is to assess the efficacy and safety of GSK4527226 in participants with early Alzheimer's Disease (AD) (including mild cognitive impairment \[MCI\] and mild dementia due to AD) of 2 dose levels of GSK4527226 compared to placebo.
Recruiting0 awards Phase 214 criteria
GSK3858279
for Osteoarthritis Pain
This trial is testing a new medication called GSK3858279 to find the best dose for reducing knee pain in people with moderate to severe osteoarthritis. The goal is to determine how much of the medication is needed to be effective and safe. This will help in managing knee pain better for those who suffer from this condition.
Recruiting0 awards Phase 2
More about Thomas Klein, MD
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Thomas Klein, MD has experience with
- Tirzepatide
- NOMAC-E2 COC
- GSK4527226
- RMenB+OMV NZ Vaccine
- MenABCWY-3
- MenABCWY-2
Breakdown of trials Thomas Klein, MD has run
Non-alcoholic Fatty Liver Disease
Fatty Liver Disease
Birth Control
Alzheimer's Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thomas Klein, MD specialize in?
Thomas Klein, MD focuses on Non-alcoholic Fatty Liver Disease and Fatty Liver Disease. In particular, much of their work with Non-alcoholic Fatty Liver Disease has involved treating patients, or patients who are undergoing treatment.
Is Thomas Klein, MD currently recruiting for clinical trials?
Yes, Thomas Klein, MD is currently recruiting for 2 clinical trials in Wichita Kansas. If you're interested in participating, you should apply.
Are there any treatments that Thomas Klein, MD has studied deeply?
Yes, Thomas Klein, MD has studied treatments such as Tirzepatide, NOMAC-E2 COC, GSK4527226.
What is the best way to schedule an appointment with Thomas Klein, MD?
Apply for one of the trials that Thomas Klein, MD is conducting.
What is the office address of Thomas Klein, MD?
The office of Thomas Klein, MD is located at: GSK Investigational Site, Wichita, Kansas 67207 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.